Skylands Capital LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 22.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 112,050 shares of the company's stock after acquiring an additional 20,725 shares during the quarter. GE HealthCare Technologies accounts for about 1.3% of Skylands Capital LLC's investment portfolio, making the stock its 20th biggest position. Skylands Capital LLC's holdings in GE HealthCare Technologies were worth $8,664,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. First Command Advisory Services Inc. grew its stake in GE HealthCare Technologies by 36,900.0% in the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company's stock worth $25,000 after purchasing an additional 369 shares in the last quarter. Fortitude Family Office LLC acquired a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $29,000. Legacy Financial Group LLC acquired a new position in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Turtle Creek Wealth Advisors LLC acquired a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $30,000. Finally, OFI Invest Asset Management acquired a new position in GE HealthCare Technologies in the third quarter valued at approximately $26,000. 82.06% of the stock is owned by hedge funds and other institutional investors.
GE HealthCare Technologies Price Performance
Shares of NASDAQ GEHC traded up $2.70 during trading on Monday, hitting $88.94. The company had a trading volume of 4,352,165 shares, compared to its average volume of 3,310,507. The company has a market cap of $40.59 billion, a P/E ratio of 29.45, a PEG ratio of 3.00 and a beta of 0.95. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The business's 50-day moving average is $88.98 and its 200 day moving average is $78.75. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to analysts' expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm's revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 earnings per share. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.13%. GE HealthCare Technologies's dividend payout ratio is currently 3.97%.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on the company. UBS Group upgraded GE HealthCare Technologies from a "sell" rating to a "neutral" rating and lifted their target price for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Argus boosted their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a "buy" rating in a research report on Monday, April 1st. Mizuho boosted their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, April 11th. Evercore ISI boosted their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an "outperform" rating in a research report on Thursday, April 4th. Finally, Morgan Stanley boosted their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an "equal weight" rating in a research report on Monday, February 12th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $95.09.
Get Our Latest Stock Report on GEHC
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Read More
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
